Ireland furthers reforms with Health Bill 2004:
This article was originally published in Clinica
The Irish government has published the Health Bill 2004 which is set to effectively centralise service delivery policy-making as part of a wider modernisation programme. From January 1, subject to the approval of the Oireachtas (parliament), the Health Service Executive will become a statutory body and replace the Eastern Regional Health Authority and the other health boards. The move promises "improved, integrated and high-quality care", based on the national implementation of best practice policy. It will also centralise political responsibility under the health ministry. HSE chairman Kevin Kelly has been appointed interim chief executive officer of the HSE. He takes up the new position on January 1, pending the appointment of a new CEO.
You may also be interested in...
A recent segment of CBS News “60 Minutes” discussing potential health benefits from probiotics was highly criticized by groups including the Consumer Healthcare Products Association, the Council for Responsible Nutrition, the Natural Products Association and the International Probiotics Association.
After a 12-month period that has seen Stada make significant investments in generics, biosimilars and consumer healthcare, CEO Peter Goldschmidt tells Generics Bulletin that the firm does not intend to stop there, as it pursues both organic and inorganic growth opportunities.
Samsung Bioepis is the latest company to stare down a lawsuit from Genentech over Avastin patents in the US. The Korean firm is aiming to be amongst the early biosimilar movers, after the market formed a year ago.